Congratulations to our alumni, Frequency Therapeutics, on receiving a $2 million U.S. Department of Defense Hearing and Balance Research Award grant to investigate Progenitor Cell Activation (PCA Regeneration).
Frequency aims to use PCA Regeneration technology to "restore hearing that has been lost as a result of military service-related injuries".
Frequency has developed their unique platform that targets the root of disease through local deliveries of small molecules to induce the regeneration of neuronal connections and hair cells for hearing.
Over 50% of battlefield situational awareness comes from hearing for active duty soldiers. Combat experience peak noise levels can reach 180 dB, and is associated with a 63% increased risk for hearing loss.
Frequency Therapeutics is making strides to improve the quality of life for the American public, veterans, service members, and those close to our soldiers.